Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Der Internist|April 1, 1993
[Palliative therapeutic control of tumor progression in patients with metastatic breast cancer]K Possinger, W Wilmanns
Onkologie|May 15, 2002
High-dose chemotherapy in high-risk primary breast cancerP Schmid, K Possinger
Zentralblatt Fur Gynakologie|January 11, 2007
[Chemotherapy for metastatic breast cancer]P Schmid, K Possinger
Onkologie|November 5, 2002
Chemotherapy for breast cancer brain metastasesM H Fenner, K Possinger
Anticancer Research|July 26, 2007
Clinical value of bisphosphonates in cancer therapyD Lüftner, P Henschke, K Possinger
The International Journal of Biological Markers|July 10, 1999
c-erbB-2 in serum of patients receiving fractionated paclitaxel chemotherapyD Lüftner, S Schnabel, K Possinger
Pharmazie in Unserer Zeit|November 22, 2001
[Real uses or just no damage? Bisphosphonates in oncology]P Schmid, O Sezer, K Possinger
MMW, Munchener Medizinische Wochenschrift|May 26, 1978
[Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs]K Possinger, R Hartenstein, H Ehrhart
Onkologie|April 1, 1981
[Current status of chemotherapy of gastric and colorectal cancer]R Hartenstein, H Ehrhart, K Possinger
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1977
[Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)]R Hartenstein, K Pfundmair, K Possinger
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Der Internist|April 1, 1993
[Palliative therapeutic control of tumor progression in patients with metastatic breast cancer]K Possinger, W Wilmanns
Onkologie|May 15, 2002
High-dose chemotherapy in high-risk primary breast cancerP Schmid, K Possinger
Zentralblatt Fur Gynakologie|January 11, 2007
[Chemotherapy for metastatic breast cancer]P Schmid, K Possinger
Onkologie|November 5, 2002
Chemotherapy for breast cancer brain metastasesM H Fenner, K Possinger
Anticancer Research|July 26, 2007
Clinical value of bisphosphonates in cancer therapyD Lüftner, P Henschke, K Possinger
The International Journal of Biological Markers|July 10, 1999
c-erbB-2 in serum of patients receiving fractionated paclitaxel chemotherapyD Lüftner, S Schnabel, K Possinger
Pharmazie in Unserer Zeit|November 22, 2001
[Real uses or just no damage? Bisphosphonates in oncology]P Schmid, O Sezer, K Possinger
MMW, Munchener Medizinische Wochenschrift|May 26, 1978
[Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs]K Possinger, R Hartenstein, H Ehrhart
Onkologie|April 1, 1981
[Current status of chemotherapy of gastric and colorectal cancer]R Hartenstein, H Ehrhart, K Possinger
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1977
[Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)]R Hartenstein, K Pfundmair, K Possinger
Pageof 17